# RedHill Biopharma Ltd. (RDHL)

> Healthcare · IL · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/RDHL/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 4.18M | $ -4.23M | $ -5.14M | $ 1.07M | $ 4.27M |
| 2024 | $ 8.45M | $ -8.69M | $ -9.86M | $ 356.0K | $ -4.68M |
| 2023 | $ 7.06M | $ 25.86M | $ -38.74M | $ 1.17M | $ 2.07M |
| 2022 | $ 69.04M | $ -80.06M | $ -32.83M | $ 122.69M | $ -48.40M |
| 2021 | $ 101.94M | $ -116.18M | $ -77.46M | $ 87.81M | $ 8.88M |
| 2020 | $ 81.99M | $ -97.04M | $ -130.48M | $ 86.90M | $ 13.86M |
| 2019 | $ 8.12M | $ -54.60M | $ -52.86M | $ 3.82M | $ 60.00M |
| 2018 | $ 11.04M | $ -51.27M | $ -46.20M | $ 0 | $ 51.19M |
| 2017 | $ 5.40M | $ -61.35M | $ -61.90M | $ 0 | $ 45.07M |
| 2016 | $ 139.0K | $ -40.41M | $ -39.04M | $ 0 | $ 62.70M |
| 2015 | $ 4.2K | $ -29.61M | $ -27.32M | $ 0 | $ 60.08M |
| 2014 | $ 9.91M | $ -15.13M | $ -18.84M | $ 0 | $ 25.01M |
| 2013 | $ 17.1K | $ -15.12M | $ -12.32M | $ 0 | $ 11.93M |
| 2012 | $ 23.1K | $ -14.91M | $ -9.97M | $ 0 | $ 19.02M |
| 2011 | $ 20.6K | $ -7.86M | $ -2.37M | $ 0 | $ 18.79M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.25 |
| Liabilities / Eq | 4.94 |
| Current Ratio | 0.34 |

## Other views

- [Metrics](https://sponda.capital/en/RDHL.md)
- [Charts](https://sponda.capital/en/RDHL/charts.md)
- [Compare](https://sponda.capital/en/RDHL/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.